SageView Advisory Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Sell
2,151
-143
-6% -$39.6K 0.02% 372
2026
Q1
$677K Sell
2,294
-6,744
-75% -$2M 0.02% 288
2025
Q4
$2.47M Sell
9,038
-1,982
-18% -$539K 0.08% 133
2025
Q3
$2.98M Buy
11,020
+6,866
+165% +$1.87M 0.1% 126
2025
Q2
$1.14M Buy
4,154
+19
+0.5% +$5.17K 0.04% 227
2025
Q1
$1.1M Sell
4,135
-1,031
-20% -$254K 0.05% 212
2024
Q4
$1.2M Buy
5,166
+2,153
+71% +$495K 0.05% 198
2024
Q3
$665K Sell
3,013
-964
-24% -$199K 0.03% 253
2024
Q2
$782K Buy
3,977
+945
+31% +$195K 0.04% 259
2024
Q1
$653K Sell
3,032
-856
-22% -$180K 0.03% 268
2023
Q4
$801K Buy
3,888
+910
+31% +$194K 0.03% 296
2023
Q3
$596K Sell
2,978
-57
-2% -$11.3K 0.03% 305
2023
Q2
$562K Sell
3,035
-2,532
-45% -$468K 0.03% 330
2023
Q1
$1.07M Buy
+5,567
New +$1.01M 0.07% 193

Other funds holding CME

SageView Advisory Group's CME Position: Q2 2026 in Review

SageView Advisory Group reduced its CME Group (CME) stake by 6.2% in Q2 2026, selling an estimated $39.6K and leaving 2,151 shares worth $475K. The position accounts for 0.02% of the portfolio, ranked #372.

SageView Advisory Group first reported a position in CME in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.98M in Q3 2025. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • SageView Advisory Group held 2,151 shares of CME Group worth $475K as of Q2 2026.
  • SageView Advisory Group sold 143 CME Group shares in Q2 2026, an estimated $39.6K.
  • CME Group made up 0.02% of SageView Advisory Group's portfolio in Q2 2026, its #372 holding.
  • SageView Advisory Group first reported a position in CME Group in Q1 2023 and has held it in 14 quarters since.
  • SageView Advisory Group's CME Group position peaked at $2.98M in Q3 2025.
  • 1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.